Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study
Author:
Affiliation:
1. Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa-shi, Japan
2. Postgraduate Education Center, Kameda Medical Center, Kamogawa-shi, Japan
3. Central laboratory, Kameda Medical Center, Kamogawa-shi, Japan
Publisher
Wiley
Subject
Hematology
Reference15 articles.
1. Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants.;Tseng;Nat Med,2022
2. Effectiveness and durability of the BNT162b2 Vaccine against Omicron sublineages in South Africa.;Collie;N Engl J Med,2022
3. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.;Nyberg;Lancet,2022
4. Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave.;Lee;Cancer Cell,2022
5. Prevalence and outcomes of COVID-19 among hematology/oncology patients and providers of a community-facing health system during the B1.1.529 (“Omicron”) SARS-CoV-2 variant wave.;Kareff;Cancers (Basel),2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3